- Home
- KPTI vs SEAT Comparison
KPTI vs SEAT Comparison
Compare KPTI & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- SEAT
- Stock Information
- Founded
- KPTI 2008
- SEAT 2001
- Country
- KPTI United States
- SEAT United States
- Employees
- KPTI N/A
- SEAT N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- KPTI Health Care
- SEAT Industrials
- Exchange
- KPTI Nasdaq
- SEAT Nasdaq
- Market Cap
- KPTI 102.4M
- SEAT 96.5M
- IPO Year
- KPTI 2013
- SEAT N/A
- Fundamental
- Price
- KPTI $6.29
- SEAT $13.49
- Analyst Decision
- KPTI Strong Buy
- SEAT Hold
- Analyst Count
- KPTI 7
- SEAT 9
- Target Price
- KPTI $31.71
- SEAT $49.89
- AVG Volume (30 Days)
- KPTI 302.2K
- SEAT 148.3K
- Earning Date
- KPTI 11-11-2025
- SEAT 11-04-2025
- Dividend Yield
- KPTI N/A
- SEAT N/A
- EPS Growth
- KPTI N/A
- SEAT N/A
- EPS
- KPTI N/A
- SEAT N/A
- Revenue
- KPTI $137,269,000.00
- SEAT $694,007,000.00
- Revenue This Year
- KPTI $3.40
- SEAT N/A
- Revenue Next Year
- KPTI $9.69
- SEAT N/A
- P/E Ratio
- KPTI N/A
- SEAT N/A
- Revenue Growth
- KPTI N/A
- SEAT N/A
- 52 Week Low
- KPTI $3.51
- SEAT $10.55
- 52 Week High
- KPTI $16.95
- SEAT $100.00
- Technical
- Relative Strength Index (RSI)
- KPTI 53.09
- SEAT 50.74
- Support Level
- KPTI $5.71
- SEAT $10.55
- Resistance Level
- KPTI $6.75
- SEAT $13.20
- Average True Range (ATR)
- KPTI 0.58
- SEAT 1.22
- MACD
- KPTI 0.03
- SEAT 0.08
- Stochastic Oscillator
- KPTI 81.25
- SEAT 64.11
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.